{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:33:10Z","timestamp":1763037190402},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00482-018-0304-8","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T11:11:21Z","timestamp":1530011481000},"page":"483-494","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neurobiologie der Opioidabh\u00e4ngigkeit","Neurobiology of opioid dependence"],"prefix":"10.1007","volume":"32","author":[{"given":"N.","family":"Scherbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"304_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL (2015) Trends in opioid analgesic abuse and mortality in the United States. N\u00a0Engl J Med 372:241\u2013248","journal-title":"N Engl J Med"},{"issue":"4","key":"304_CR2","first-page":"45","volume":"110","author":"I Schubert","year":"2013","unstructured":"Schubert I, Ihle P, Sabatowski R (2013) Zunahme der Opioidverordnungen in Deutschland zwischen 2000 und 2010. Dtsch \u00c4rztebl Int 110(4):45\u201351","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"304_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain0000000000001067","author":"W H\u00e4user","year":"2017","unstructured":"H\u00e4user W, Schubert T, Scherbaum N, T\u00f6lle T (2017) Guideline-recommended vs. high-dose long-term opioid therapy for chronic non-cancer pain is associated with better health outcomes: data from representative sample of the German population. Pain. https:\/\/doi.org\/10.1097\/j.pain0000000000001067","journal-title":"Pain"},{"key":"304_CR4","volume-title":"Drogen- und Suchtbericht Juli 2017","author":"Die Drogenbeauftragte der Bundesregierung","year":"2017","unstructured":"Die Drogenbeauftragte der Bundesregierung (2017) Drogen- und Suchtbericht Juli 2017. www.drogenbeauftragte.de"},{"key":"304_CR5","volume-title":"Europ\u00e4ischer Drogenbericht \u2013 Trends und Entwicklungen","author":"Europ\u00e4ische Beobachtungsstelle f\u00fcr Drogen und Drogensucht","year":"2017","unstructured":"Europ\u00e4ische Beobachtungsstelle f\u00fcr Drogen und Drogensucht (2017) Europ\u00e4ischer Drogenbericht \u2013 Trends und Entwicklungen. Amt f\u00fcr Ver\u00f6ffentlichungen der Europ\u00e4ischen Union, Luxemburg"},{"key":"304_CR6","doi-asserted-by":"crossref","DOI":"10.17433\/978-3-17-023564-9","volume-title":"Neurobiologie der Abh\u00e4ngigkeit","author":"A Heinz","year":"2012","unstructured":"Heinz A, Batra A, Scherbaum N, Gouzoulis-Mayfrank E (2012) Neurobiologie der Abh\u00e4ngigkeit. Kohlhammer, Stuttgart"},{"key":"304_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00103-015-2264-9","volume":"59","author":"I Sch\u00e4fer","year":"2016","unstructured":"Sch\u00e4fer I, Barnow S, Pawils S, CANSAS Study Group (2016) Substanzbezogene St\u00f6rungen als Ursache und als Folge fr\u00fcher Gewalt. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 59:35\u201343","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"304_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1055\/s-0038-1627034","volume":"36","author":"H K\u00fcfner","year":"2017","unstructured":"K\u00fcfner H, Soyka M (2017) Psychologische Suchttheorien als Erkl\u00e4rungsans\u00e4tze. Nervenheilkunde 36:439\u2013456","journal-title":"Nervenheilkunde"},{"key":"304_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0033-1363240","volume":"15","author":"N Scherbaum","year":"2014","unstructured":"Scherbaum N, Specka M (2014) Komorbide psychische St\u00f6rungen bei Opiatabh\u00e4ngigen. Suchttherapie 15:22\u201328","journal-title":"Suchttherapie"},{"issue":"11","key":"304_CR10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","volume":"142","author":"EJ Khantzian","year":"1985","unstructured":"Khantzian EJ (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 142(11):1259\u20131264","journal-title":"Am J Psychiatry"},{"key":"304_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/mp.2012.151","volume":"18","author":"KS Kendler","year":"2013","unstructured":"Kendler KS (2013) Decision making in the pathway from genes to psychiatric and substance use disorders. Mol Psychiatry 18:640\u2013645","journal-title":"Mol Psychiatry"},{"key":"304_CR12","first-page":"17","volume-title":"Textbook of Substance Abuse Treatment","author":"J Gelernter","year":"2008","unstructured":"Gelernter J, Kranzler HR (2008) Genetics of addiction. In: Galanter M, Kleber HD (Hrsg) Textbook of Substance Abuse Treatment, 4.\u00a0Aufl. American Psychiatric Publishing, Washington, London, S\u00a017\u201327","edition":"4"},{"issue":"7","key":"304_CR13","doi-asserted-by":"publisher","first-page":"e0159045","DOI":"10.1371\/journal.pone.0159045","volume":"11","author":"M Meulen van der","year":"2016","unstructured":"van der Meulen M, van Ijzendoorn MH, Crone EA (2016) Neural correlates of prosocial behavior: compensating social exclusion in a\u00a0four-player cyberball game. PLoS ONE 11(7):e159045","journal-title":"PLoS ONE"},{"key":"304_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1037\/h0058775","volume":"47","author":"J Olds","year":"1954","unstructured":"Olds J, Milner P (1954) Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J\u00a0Comp Physiol Psychol 47:419\u2013427","journal-title":"J Comp Physiol Psychol"},{"key":"304_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.euroneuro.2017.08.430","volume":"27","author":"U Bonnet","year":"2017","unstructured":"Bonnet U, Scherbaum N (2017) How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol 27:1185\u20132015","journal-title":"Eur Neuropsychopharmacol"},{"key":"304_CR16","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1098\/rstb.2006.1854","volume":"361","author":"RA Wise","year":"2006","unstructured":"Wise RA (2006) Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond, B, Biol Sci 361:1149\u20131158","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"key":"304_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","volume":"28","author":"KC Berridge","year":"1998","unstructured":"Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Rev 28:309\u2013369","journal-title":"Brain Res Rev"},{"issue":"5","key":"304_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-6147(92)90062-B","volume":"13","author":"G Chiara Di","year":"1992","unstructured":"Di Chiara G, North RA (1992) Neurobiology of opiate abuse. Trends Pharmacol Sci 13(5):185\u2013193","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"304_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76(3):470\u2013485","journal-title":"Neuron"},{"key":"304_CR20","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1126\/science.275.5306.1593","volume":"275","author":"W Schultz","year":"1997","unstructured":"Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593\u20131599","journal-title":"Science"},{"key":"304_CR21","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1176\/appi.ajp.159.10.1642","volume":"159","author":"RZ Goldstein","year":"2002","unstructured":"Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642\u20131652","journal-title":"Am J Psychiatry"},{"issue":"6","key":"304_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1176\/appi.ajp.2015.14101249","volume":"172","author":"LM Squeglia","year":"2015","unstructured":"Squeglia LM, Tapert SF, Sullivan EV, Jacobus J, Meloy MJ, Rohlfing T, Pfefferbaum A (2015) Brain development in heavy-drinking adolescents. Am J Psychiatry 172(6):531\u2013542","journal-title":"Am J Psychiatry"},{"key":"304_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1055\/s-0043-100763","volume":"85","author":"H Dirks","year":"2017","unstructured":"Dirks H, Scherbaum N, Kis B, Mette C (2017) ADHS im Erwachsenenalter und substanzbezogene St\u00f6rungen \u2013 Pr\u00e4valenz, Diagnostik und integrierte Behandlungskonzepte. Fortschr Neurol Psychiatr 85:336\u2013344","journal-title":"Fortschr. Neurol. Psychiatr."},{"issue":"11","key":"304_CR24","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/nn1584","volume":"8","author":"A Bechara","year":"2005","unstructured":"Bechara A (2005) Decision making, impulse control and loss of willpower to resist drugs: a\u00a0neurocognitive perspective. Nat Neurosci 8(11):1458\u20131463","journal-title":"Nat Neurosci"},{"key":"304_CR25","first-page":"1","volume":"30","author":"MS Gold","year":"1979","unstructured":"Gold MS, Byck R, Sweeney DR, Kleber HD (1979) Endorphin-locus coeruleus connection mediates opiate action and withdrawal. Biomedicine (Taipei) 30:1\u20134","journal-title":"Biomedicine (Taipei)"},{"key":"304_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.pnpbp.2009.03.008","volume":"33","author":"B Lieb","year":"2009","unstructured":"Lieb B, Bonnet U, Specka M, Augener S, Bachmann HS, Siffert W, Scherbaum N (2009) Intensity of opiate withdrawal in relation to the 825\u202fC>T-polymorphism of the G protein beta 3 subunit gene. Progr Neuropsychopharmacol Biol Psych 33:663\u2013667","journal-title":"Progr. Neuropsychopharmacol. Biol. Psych."},{"key":"304_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1055\/s-0033-1335646","volume":"81","author":"N Scherbaum","year":"2013","unstructured":"Scherbaum N, Lieb B (2013) Opioidabh\u00e4ngigkeit. Fortschr Neurol Psychiatr 81:346\u2013358","journal-title":"Fortschr Neurol Psychiatr"},{"key":"304_CR28","first-page":"14","volume":"72","author":"N Scherbaum","year":"2004","unstructured":"Scherbaum N, Heppekausen K, Rist F (2004) Sind Abbr\u00fcche im methadongest\u00fctzten Opiatentzug bedingt durch Entzugssymptomatik oder Suchtmittelverlangen? Fortschr Neurol Psychiatr 72:14\u201320","journal-title":"Fortschr. Neurol. Psychiatr."},{"key":"304_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/alcalc\/34.2.197","volume":"34","author":"R Verheul","year":"1999","unstructured":"Verheul R, van den Brink W, Greelings P (1999) A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 34:197\u2013222","journal-title":"Alcohol Alcohol"},{"key":"304_CR30","volume-title":"Sucht und Mi\u00dfbrauch","year":"1964","unstructured":"Laubenthal F (Hrsg) (1964) Sucht und Mi\u00dfbrauch. Thieme, Stuttgart"},{"key":"304_CR31","volume-title":"Opium \u2013 eine Kulturgeschichte","author":"M Seefelder","year":"1996","unstructured":"Seefelder M (1996) Opium \u2013 eine Kulturgeschichte. Nikol Verlagsgesellschaft, Hamburg"},{"issue":"7619","key":"304_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature19112","volume":"537","author":"A Manglik","year":"2016","unstructured":"Manglik A, Lin H, Aryal DK, McCorvy JD, Dengler D, Corder G, Levit A, Kling RC, Bernat V, H\u00fcbner H, Huang XP, Sassano MF, Gigu\u00e8re PM, L\u00f6ber S, Da Duan, Scherrer G, Kobilka BK, Gmeiner P, Roth BL, Shoichet BK (2016) Structure-based discovery of opioid analgesics with reduced side effects. Nature 537(7619):185\u2013190","journal-title":"Nature"},{"key":"304_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13181-012-0263-x","volume":"8","author":"R Wightman","year":"2012","unstructured":"Wightman R, Perrone J, Portelli I, Nelson L (2012) Likeability and abuse liability of commonly prescribed opioids. J\u00a0Med Toxicol 8:335\u2013340","journal-title":"J Med Toxicol"},{"key":"304_CR34","first-page":"235","volume":"34","author":"A Ippolito","year":"2016","unstructured":"Ippolito A, Raimann F, Warszawska J, Zacharowski K, Pape A (2016) Opioide in der An\u00e4sthesie. Arzneimitteltherapie 34:235\u2013242","journal-title":"Arzneimitteltherapie"},{"issue":"3","key":"304_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11916-018-0670-z","volume":"22","author":"N Vadivelu","year":"2018","unstructured":"Vadivelu N, Kai AM, Kodumudi V, Sramcik J, Kaye AD (2018) The Opioid Crisis: a\u00a0Comprehensive Overview. Curr Pain Headache Rep 22(3):16. https:\/\/doi.org\/10.1007\/s11916-018-0670-z","journal-title":"Curr Pain Headache Rep"},{"key":"304_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.drugalcdep.2015.05.010","volume":"153","author":"DS Fink","year":"2015","unstructured":"Fink DS, Hu R, Cerd\u00e1 M, Keyes KM, Marshall BDL, Galea S, Martins SS (2015) Patterns of major depression and nonmedical use of prescription opioids in the United States. Drug Alcohol Depend 153:258\u2013264","journal-title":"Drug Alcohol Depend"},{"key":"304_CR37","first-page":"337","volume-title":"Schmerzmedizin","author":"A Schwarzer","year":"2016","unstructured":"Schwarzer A, Scherbaum N, Kindler D, Maier C (2016) Diagnostik, Therapie und Pr\u00e4vention der Opioidabh\u00e4ngigkeit. In: Maier C, Diener H\u2011C, Bingel U (Hrsg) Schmerzmedizin, 5.\u00a0Aufl. Urban & Fischer\/Elsevier, M\u00fcnchen Jena, S 337\u2013352","edition":"5"},{"key":"304_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1055\/s-0038-1628851","volume":"29","author":"M Spitzer","year":"2010","unstructured":"Spitzer M (2010) Geist & Gehirn: Dopamin und K\u00e4sekuchen. Essen als Suchtverhalten. Nervenheilkunde 29:482\u2013486","journal-title":"Nervenheilkunde"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-018-0304-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-018-0304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-018-0304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T10:27:17Z","timestamp":1693736837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-018-0304-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1007\/s00482-018-0304-8","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"26 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Scherbaum erhielt Honorare f\u00fcr T\u00e4tigkeiten in Advisory Boards, Vortragst\u00e4tigkeit, Erstellung von Manuskripten sowie Erstellung von Weiterbildungsmaterial von den Firmen AbbVie, Janssen-Cilag, Lundbeck, Medice, Mundipharma, Reckitt-Benckiser\/Indivior und Sanofi-Aventis erhalten. Er hat in den letzten 3\u00a0Jahren an Medikamentenpr\u00fcfungen teilgenommen, die von der pharmazeutischen Industrie finanziert wurden. U.\u00a0Bonnet gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die im Beitrag zitierten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}